Patient outcome in migraine prophylaxis: the role of psychopharmacological agents - sprookjes - yvandenbroek - TriplyDB

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents

http://www.wikidata.org/entity/Q36160565

about

Hearing voices: does it give your patient a headache? A case of auditory hallucinations as acoustic aura in migraine.White matter hyperintensities and self-reported depression in a sample of patients with chronic headache Alexithymia and its impact on quality of life in a group of Brazilian women with migraine without aura.Prevalence of migraine and co-morbid psychiatric disorders among students of Cumhuriyet University Biomarkers associated with migraine and their potential role in migraine management.Recent Approaches and Development of Acupuncture on Chronic Daily Headache.A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraine.The psychometric properties of the persian migraine-specific quality of life questionnaire version 2.1 in episodic and chronic migraines.

P2860

Q30468295-6E748FC8-6D77-41D2-AF3B-64BD8E3AA62A Q36357119-E7A78D2F-42F5-43A8-BDC6-42F20907000B Q36750187-40B8ED54-EB9B-4698-97F5-A1E85D8A558F Q36803338-951EC9C2-B61F-46C4-B0B8-272FA46321C0 Q38121110-8BF4CC05-9C4C-4B3B-8B39-6EB1FB7E4C5F Q38678195-CFA4B695-294E-4E65-844B-4E597DC9DE61 Q42617959-DACBA0A1-3452-4E54-84D7-39185A11C559 Q52926317-B4816008-4CFE-467F-A5F3-23E9E377E8EC

P2860

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents

http://www.wikidata.org/entity/Q36160565

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents

@ast

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents

@en

type

label

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents

@ast

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents

@en

prefLabel

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents

@ast

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents

@en

P1433

Q36160565-455FAAEF-0ACF-4321-9421-CE4317530190

P1476

Q36160565-2D492094-3AC7-4ED0-9F49-F91458AA6207

P2093

Q36160565-1502E5BF-A620-4CC1-AAB2-2C0520A05E8F

Q36160565-71AD05C0-F119-4302-9ED8-8ED4B848753F

Q36160565-7231E59D-2BED-40D9-80F0-C216906712EA

Q36160565-82780202-03B2-4E2E-A107-98DFB1A80B4D

Q36160565-B1A9B8B2-D5A1-4E5D-AD6D-D0B4AE5904DD

Q36160565-ECFE9AE8-981C-4D9D-9B4A-E39D523AF6E5

P2860

Q36160565-0309C748-33EB-4691-94DE-F5054AFC557D

Q36160565-0C8266A8-F5B3-4075-A811-DC6B0B58C5A9

Q36160565-0EEFFEAF-9164-4E4E-956D-3664C22F1E24

Q36160565-110A844F-1CFD-47CD-91EE-9F31D1C2A0FF

Q36160565-14F47BD4-AD15-4DCE-89CC-371025DAF007

Q36160565-1F01D588-F866-4152-9628-E6B373A04EDC

Q36160565-1F7A5EA5-0F61-4389-B292-039E642DD77E

Q36160565-23136E5A-872A-4ADA-99AD-5D2E91933528

Q36160565-27DBAEA2-052D-4B9F-BE5C-5C5DD7C161B0

Q36160565-2D36AFF7-24C6-45E3-B0B7-94118CA6B614

P304

Q36160565-6F7D6CE7-130C-4550-A9B3-ECF68964645E

P31

Q36160565-F2FCCEF6-1EC3-47FE-A0B0-98580F1CC340

P356

Q36160565-32D77BC5-9D64-4378-A3B0-937B7289D7BC

P478

Q36160565-6327BCF3-51CA-4546-B4AE-781666868DFF

P50

Q36160565-1C0F0012-4B64-4D9E-87F9-97AD174BF570

Q36160565-3A5CE63B-41A9-4C06-BE56-6CD47E104659

Q36160565-5A7F7F4C-4A77-49B9-B65E-C0470B04CD8A

Q36160565-5CC4A746-D248-47ED-8128-867240571CBE

Q36160565-9656FC73-D5E5-478C-9B11-DDFE3A78B79D

Q36160565-F07B72E9-0516-49C0-B70B-7257F327EFCA

P577

Q36160565-20135098-0E3A-44B1-9D3E-B9F1FD1E99D5

P698

Q36160565-0829378E-B93C-44AA-9C17-1E1C585297B1

P921

Q36160565-1EAE1A9D-6D6F-44BF-A32B-FB493858702E

Q36160565-CEA4FBC7-951E-477E-85BD-03064A321292

P932

Q36160565-A45EE980-3662-40DC-BBED-E7249EE69220

P356

P1433

Patient Related Outcome Measures

P1476

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents

@en

P2093

Giovanni Dominici

http://www.w3.org/2001/XMLSchema#string

Giulia Serra

http://www.w3.org/2001/XMLSchema#string

Juliana Fortes-Lindau

http://www.w3.org/2001/XMLSchema#string

Ludovica Telesforo

http://www.w3.org/2001/XMLSchema#string

Maurizio Pompili

http://www.w3.org/2001/XMLSchema#string

Monica Pastina

http://www.w3.org/2001/XMLSchema#string

P2860

Acupuncture for migraine prophylaxis

Anticonvulsant drugs for migraine prophylaxis

Propranolol for migraine prophylaxis

Systematic reviews of complementary therapies - an annotated bibliography. Part 1: acupuncture

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study

Neurogenic inflammation and migraine: implications for the therapeutics

5-HT2 receptor antagonists and migraine therapy

Suppression of cortical spreading depression in migraine prophylaxis

Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study

P304

107-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/PROM.S9742

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Tatarelli

Marco Innamorati

Paolo Martelletti

Gianluca Serafini

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22915957

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

P932

3417910

http://www.w3.org/2001/XMLSchema#string